You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Parameters for survival

From: Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study

  Dosis 1 Dosis 2
  Survived Lost to Follow up Survived Lost to Follow up Survived Lost to Follow up
1 year 6 0 3 0 9 0
3 years 3 0 0 3 3 3
  1. One year after initiation all patients were alive, three patients had died of tumor progression within the following three years.